Malignant mesothelioma is the deadliest of several diseases that are caused by exposure to asbestos. Others include asbestosis and asbestos-related lung cancer. Scientists have determined many incontrovertible facts about the impact of asbestos on the human body: among these is the fact that smoking cigarettes while at the same time exposed to asbestos exacerbates the impact of the carcinogen and makes it even more likely that the toxic exposure will lead to illness. Unfortunately, upon learning that a person diagnosed with one of these diseases was also a smoker, many asbestos companies facing legal action argue against their own legal responsibility, blaming the smoking for the illness instead. Such a case is currently proceeding through the courts, as ex-railroad worker Kevin E. Howell has filed suit against Consolidated Rail Corporation.
Month: July 2017
If you have been diagnosed with malignant mesothelioma, you have a lot of realities that you must deal with in a short period of time. Mesothelioma is a rare and always fatal form of cancer that is caused by exposure to asbestos, and a diagnosis means that you need to give consideration to your family, your treatment options, your legal options, and how you are going to address important end-of-life issues. On the long list of arrangements and options you may want to consider, it’s important that you understand the many benefits that hospice care can offer to you and your family.
An exciting worldwide clinical trial has just been announced by drug giant Boehringer Ingelheim to see whether patients diagnosed with unresectable malignant pleural mesothelioma are able to get benefit from a new combination of drugs. The combination would pair the company’s nintedanib – a drug used in the treatment of pulmonary fibrosis – with the standard mesothelioma chemotherapy treatment of both Platinol (cisplatin) and Alimta (pemetrexed) to see whether the addition of the drug to that already accepted therapy provides any additional effectiveness of extension of survival.
There are certain occupations and life choices that are known to be at high risk for a mesothelioma diagnosis. These are generally jobs that involve high heat environments such as factory settings or oil refineries, or environments that require foundational strength such as infrastructure and construction jobs. One would never associate teenaged girls with having a high risk for diagnosis with this rare form of cancer. Unfortunately, news has just been released regarding asbestos contamination in a brand of makeup being sold at a popular teen clothing store. The product specifically targets young girls, raising the risk that those who have purchased and used it will have to monitor their health for signs of the asbestos-related disease for decades to come.
Today, it is well known that asbestos is a dangerous carcinogenic material and that it causes malignant mesothelioma, asbestosis, and other serious diseases. Its use has been largely curtailed in the United States, and when it is used those who are in its proximity are generally provided with protective clothing and clear warnings regarding its dangers. But this was not always the case. It was not until the mid-1970s that the Environmental Protection Agency alerted the public to the dangers of this widely-used mineral and precautions began to be taken. This does not mean that the companies that used asbestos in their products were unaware of its dangers: in fact, it has been discovered that most were aware of the hazards of asbestos exposure but chose to continue its use because it added to their profits. As a result, untold numbers of innocent people have lost their good health or their lives to asbestos-related diseases, and many of them served in the military. One of those affected is Darrel E. Keller, a former machinist who served in the U.S. Navy between 1959 and 1966. Mr. Keller was recently diagnosed with asbestosis, and is now suing several companies that he holds responsible for his illness.
In the search for a cure for malignant mesothelioma, the rare and deadly form of cancer caused by exposure to asbestos, scientists have repeatedly run into disappointing roadblocks. Promising therapies repeatedly fall short, leaving researchers frustrated and sending them back to the drawing board. But a recent study that combined two of those disappointing therapies into a single treatment is raising hopes for mesothelioma patients and advocates alike: according to a study published in the journal Cancer Immunology Research, researchers from the National Cancer Institute and Roche Pharmaceutical Research succeeded in eradicating mesothelioma in most mice involved in their study.